| Entry |
|
| Name |
Dopamine-DRD-GNAI/O signaling pathway
|
| Definition |
Dopamine -> DRD -> (GNAI,GNAO) -| ADCY5 |
| Expanded |
C03758 -> (1813,1814,1815) -> ((2770,2771,2773),2775) -| 111 |
| Class |
nt06544 Neuroactive ligand signaling
|
| Type |
Reference
|
| Pathway |
|
| Gene |
| 1813 | DRD2; dopamine receptor D2 |
| 1814 | DRD3; dopamine receptor D3 |
| 1815 | DRD4; dopamine receptor D4 |
| 2770 | GNAI1; G protein subunit alpha i1 |
| 2771 | GNAI2; G protein subunit alpha i2 |
| 2773 | GNAI3; G protein subunit alpha i3 |
| 2775 | GNAO1; G protein subunit alpha o1 |
| 111 | ADCY5; adenylate cyclase 5 |
|
| Metabolite |
|
| Reference |
|
| Authors |
Channer B, Matt SM, Nickoloff-Bybel EA, Pappa V, Agarwal Y, Wickman J, Gaskill PJ |
| Title |
Dopamine, Immunity, and Disease. |
| Journal |
|
| Reference |
|
| Authors |
Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG |
| Title |
Dopamine: Functions, Signaling, and Association with Neurological Diseases. |
| Journal |
|
| LinkDB |
|